Viewing Study NCT00004050


Ignite Creation Date: 2025-12-24 @ 5:08 PM
Ignite Modification Date: 2026-01-27 @ 1:44 AM
Study NCT ID: NCT00004050
Status: TERMINATED
Last Update Posted: 2014-07-29
First Post: 1999-12-10
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Leuvectin Followed By Surgery in Treating Patients With Stage II or Stage III Prostate Cancer
Sponsor: Vical
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Prostate Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None stage IIB prostate cancer View
None stage IIA prostate cancer View
None stage III prostate cancer View